A unique platform to discover novel peptides that normalize cellular micro-environments
Micro-enviroments in cells become dysregulated with disease progression and prolonged treatments (treatment resistance)
FIRST THERAPEUTIC TARGETHORMONE-SENSITIVE CANCERSA novel co-treatment for Treatment Resistant Prostate Cancer by normalizing iron dysregulation in PC tumor cells
SITE UNDER CONSTRUCTION